Latest Developments in Global Reprocessed Medical Devices Market

back-icon

Back to Report

Request for TOC Request for TOC Speak to Analyst Speak to Analyst Free Sample Report Free Sample Report Inquire Before Buying Inquire Before Buy Now Buy Now

Latest Developments in Global Reprocessed Medical Devices Market

  • Medical Devices
  • Aug 2024
  • Global
  • 350 Pages
  • No of Tables: 220
  • No of Figures: 60

  • In April 2023, Stryker’s Sustainability Solutions, a leader in third-party reprocessing, expanded its cardiovascular device reprocessing program to include more electrophysiology catheters, helping hospitals reduce costs and medical waste. This initiative underscores Stryker’s commitment to environmental stewardship and cost containment in healthcare, while ensuring safety through FDA-compliant reprocessing protocols. The expansion is part of a broader effort to increase the scope of devices eligible for high-quality reuse in U.S. healthcare systems
  • In March 2023, Innovative Health, a prominent U.S.-based reprocessing company, announced a collaboration with a leading hospital network to reprocess advanced mapping catheters used in cardiac procedures. The partnership is expected to generate substantial cost savings for the network while promoting more sustainable procurement practices. This development reflects growing confidence in the safety and effectiveness of reprocessed high-tech medical devices
  • In March 2023, the European Commission issued updated guidance on medical device reprocessing across EU member states, promoting the safe reuse of certain single-use devices under standardized conditions. This regulatory update supports harmonization and expands the adoption of reprocessing practices in public health institutions, further enabling cost-efficient healthcare delivery across the region. It also underscores Europe’s broader commitment to sustainability in medical systems
  • In February 2023, Vanguard AG, a Germany-based reprocessing company, reported increased demand for its services in orthopedic and general surgery devices. The company highlighted a 25% year-over-year rise in contracts from hospitals aiming to reduce waste and operational costs. This surge illustrates the growing acceptance of reprocessing as a viable tool in Europe’s healthcare cost-containment strategies
  • In January 2023, Medline ReNewal, a division of Medline Industries, announced the launch of an advanced tracking and reporting system for reprocessed surgical instruments. The new platform provides hospitals with real-time data on reprocessed device usage, savings, and environmental impact. This innovation reinforces Medline’s commitment to transparency, traceability, and sustainable healthcare solutions while enhancing operational efficiency for healthcare providers